Correlation Between Longboard Pharmaceuticals and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Longboard Pharmaceuticals and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longboard Pharmaceuticals and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longboard Pharmaceuticals and NextCure, you can compare the effects of market volatilities on Longboard Pharmaceuticals and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longboard Pharmaceuticals with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longboard Pharmaceuticals and NextCure.

Diversification Opportunities for Longboard Pharmaceuticals and NextCure

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Longboard and NextCure is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Longboard Pharmaceuticals and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Longboard Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longboard Pharmaceuticals are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Longboard Pharmaceuticals i.e., Longboard Pharmaceuticals and NextCure go up and down completely randomly.

Pair Corralation between Longboard Pharmaceuticals and NextCure

Given the investment horizon of 90 days Longboard Pharmaceuticals is expected to generate 1.15 times more return on investment than NextCure. However, Longboard Pharmaceuticals is 1.15 times more volatile than NextCure. It trades about 0.12 of its potential returns per unit of risk. NextCure is currently generating about 0.02 per unit of risk. If you would invest  1,938  in Longboard Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  4,060  from holding Longboard Pharmaceuticals or generate 209.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Longboard Pharmaceuticals  vs.  NextCure

 Performance 
       Timeline  
Longboard Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Longboard Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Longboard Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Longboard Pharmaceuticals and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Longboard Pharmaceuticals and NextCure

The main advantage of trading using opposite Longboard Pharmaceuticals and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longboard Pharmaceuticals position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Longboard Pharmaceuticals and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios